RSS Roche Announces Approval Of Vabysmo Prefilled Syringe In The EU - Quick Facts

Currently reading:
 RSS Roche Announces Approval Of Vabysmo Prefilled Syringe In The EU - Quick Facts

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
6,209
Likes
1,916
Credits
32,769©
Cash
0$
Roche (RHHBY) has announced that the European Medicines Agency has granted approval for Vabysmo, or faricimab, as a single-dose prefilled syringe containing 6.0 mg. This medication is intended for treating conditions such as neovascular or 'wet' age-related macular degeneration, diabetic macular edema, and macular edema resulting from retinal vein occlusion. The prefilled syringe format of Vabysmo offers the same therapeutic solution as the existing 6.0 mg Vabysmo vials but in a more convenient, ready-to-use form. Roche highlighted that Vabysmo PFS is notable for being the first and only CE-labelled needle designed specifically for intravitreal injection, enhancing ophthalmologists' treatment options.

Levi Garraway, the Chief Medical Officer and Head of Global Product Development at Roche, stated: "This streamlined administration approach may help lessen the treatment demands on patients and retina specialists alike."

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips
Top Bottom